Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2017

29.11.2016 | Gastrointestinal Oncology

Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons

verfasst von: Allison H. Maciver, MD, FRCSC, Eisar Al-Sukhni, MD, FRCSC, Jesus Esquivel, MD, FACS, Joseph J. Skitzki, MD, FACS, John M. Kane III, MD, FACS, Valerie A. Francescutti, MD, FRCSC, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Cytoreductive surgery and heated intraperitoneal chemotherapy (CS/HIPEC) is performed for selected indications at a limited number of specialized centers worldwide. Currently there is no standardized approach to the perioperative care process. We sought to capture current practices in the perioperative management of patients who undergo CS/HIPEC at high-volume centers.

Methods

Surgeon members of the American Society of Peritoneal Surface Malignancies working at high-volume CS/HIPEC centers (>10 cases/year) were invited to complete an online survey. The survey included questions relating to preoperative preparation of patients, intraoperative practices, and postoperative care.

Results

Ninety-seven surgeons from five continents completed the survey (response rate 55%). The majority (80%) practiced in academic environments. Most respondents (68%) indicated that a formal preoperative preparatory pathway for CS/HIPEC surgery existed at their centers, but few (26%) had used enhanced recovery protocols in this group of patients. Whereas the intraoperative technical practices of the CS/HIPEC procedure were relatively consistent across respondents, there was little agreement on pre- and postoperative care practices, including use of mechanical bowel preparation, nutritional supplementation, methods of perioperative analgesia, timing of physical therapy and ambulation, nasogastric tube and Foley removal, intravenous fluids, blood transfusion parameters, and postoperative use of deep-vein thrombosis prophylaxis and antibiotics.

Conclusions

Perioperative care practices for CS/HIPEC are widely variable nationally and internationally. Standardization of such practices offers an opportunity to incorporate evidence-based interventions and may enhance patient outcomes and improve care standards across all centers that offer this procedure.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16(8):2152–65. doi:10.1245/s10434-009-0487-4.CrossRefPubMed Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16(8):2152–65. doi:10.​1245/​s10434-009-0487-4.CrossRefPubMed
5.
6.
8.
Zurück zum Zitat Braam HJ, Boerma D, Wiezer MJ, van Ramshorst B. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists. Int J Clin Oncol. 2015;20(5):928–34. doi:10.1007/s10147-015-0816-5.CrossRefPubMed Braam HJ, Boerma D, Wiezer MJ, van Ramshorst B. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists. Int J Clin Oncol. 2015;20(5):928–34. doi:10.​1007/​s10147-015-0816-5.CrossRefPubMed
9.
Zurück zum Zitat Tabrizian P, Overbey J, Carrasco-Avino G, Bagiella E, Labow DM, Sarpel U. Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Ann Surg Oncol. 2015;22(5):1746–50. doi:10.1245/s10434-014-4220-6.CrossRefPubMed Tabrizian P, Overbey J, Carrasco-Avino G, Bagiella E, Labow DM, Sarpel U. Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Ann Surg Oncol. 2015;22(5):1746–50. doi:10.​1245/​s10434-014-4220-6.CrossRefPubMed
10.
Zurück zum Zitat Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249(6):900–7. doi:10.1097/SLA.0b013e3181a45d86.CrossRefPubMed Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249(6):900–7. doi:10.​1097/​SLA.​0b013e3181a45d86​.CrossRefPubMed
11.
Zurück zum Zitat Moradi BN, Esquivel J. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Piso P, Nissan A, eds. J Surg Oncol. 2009;100(4):293–6. doi:10.1002/jso.21326. Moradi BN, Esquivel J. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Piso P, Nissan A, eds. J Surg Oncol. 2009;100(4):293–6. doi:10.​1002/​jso.​21326.
12.
Zurück zum Zitat Kusamura S, Moran BJ, Sugarbaker PH, et al. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg. 2014;101(13):1758–65. doi:10.1002/bjs.9674.CrossRefPubMed Kusamura S, Moran BJ, Sugarbaker PH, et al. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg. 2014;101(13):1758–65. doi:10.​1002/​bjs.​9674.CrossRefPubMed
13.
Zurück zum Zitat Esquivel J. Current status and future directions of hyperthermic intraperitoneal chemotherapy (HIPEC). Int Oncol. 2014;2(6):E45–52. Esquivel J. Current status and future directions of hyperthermic intraperitoneal chemotherapy (HIPEC). Int Oncol. 2014;2(6):E45–52.
17.
Zurück zum Zitat Esquivel J, Stojadinovic A, Levine EA. The American Society of Peritoneal Surface Malignancies (ASPSM). Ann Surg Oncol. 2011;18 Suppl 3(S3):S218–9. doi:10.1245/s10434-010-1402-8. Esquivel J, Stojadinovic A, Levine EA. The American Society of Peritoneal Surface Malignancies (ASPSM). Ann Surg Oncol. 2011;18 Suppl 3(S3):S218–9. doi:10.​1245/​s10434-010-1402-8.
18.
Zurück zum Zitat Turaga K, Levine E, Barone R, et al. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501–5. doi:10.1245/s10434-013-3061-z.CrossRefPubMed Turaga K, Levine E, Barone R, et al. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501–5. doi:10.​1245/​s10434-013-3061-z.CrossRefPubMed
19.
Zurück zum Zitat Lv L, Shao Y-F, Zhou Y-B. The enhanced recovery after surgery (ERAS) pathway for patients undergoing colorectal surgery: an update of meta-analysis of randomized controlled trials. Int J Colorectal Dis. 2012;27(12):1549–54. doi:10.1007/s00384-012-1577-5.CrossRefPubMed Lv L, Shao Y-F, Zhou Y-B. The enhanced recovery after surgery (ERAS) pathway for patients undergoing colorectal surgery: an update of meta-analysis of randomized controlled trials. Int J Colorectal Dis. 2012;27(12):1549–54. doi:10.​1007/​s00384-012-1577-5.CrossRefPubMed
21.
Zurück zum Zitat Dillman D, Smyth JD, Christian LM. Nternet, phone, mail, and mixed-mode surveys: the tailored design method, 4th edn. Hoboken, NJ: Wiley; 2014. Dillman D, Smyth JD, Christian LM. Nternet, phone, mail, and mixed-mode surveys: the tailored design method, 4th edn. Hoboken, NJ: Wiley; 2014.
22.
Zurück zum Zitat National Comprehensive Cancer Network NCCN. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. National Comprehensive Cancer Network NCCN. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer.
23.
Zurück zum Zitat Francescutti V, Skitzki JJ, Kane JM, Simunovic M. A comprehensive evaluation of barriers to referral of patients for Cytoreduction/Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC). Francescutti V, Skitzki JJ, Kane JM, Simunovic M. A comprehensive evaluation of barriers to referral of patients for Cytoreduction/Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC).
24.
Zurück zum Zitat Hamilton TD, Taylor EL, Cannell AJ, McCart JA, Govindarajan A. Impact of major complications on patients’ quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. April 2016. doi:10.1245/s10434-016-5231-2. Hamilton TD, Taylor EL, Cannell AJ, McCart JA, Govindarajan A. Impact of major complications on patients’ quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. April 2016. doi:10.​1245/​s10434-016-5231-2.
26.
Zurück zum Zitat Polanco PM, Ding Y, Knox JM, et al. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol. 2015;22(5):1673–9. doi:10.1245/s10434-014-4111-x.CrossRefPubMed Polanco PM, Ding Y, Knox JM, et al. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol. 2015;22(5):1673–9. doi:10.​1245/​s10434-014-4111-x.CrossRefPubMed
28.
Zurück zum Zitat Dineen SP, Robinson KA, Roland CL, et al. Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. J Surg Res. 2016;200(1):158–63. doi:10.1016/j.jss.2015.08.003.CrossRefPubMed Dineen SP, Robinson KA, Roland CL, et al. Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. J Surg Res. 2016;200(1):158–63. doi:10.​1016/​j.​jss.​2015.​08.​003.CrossRefPubMed
Metadaten
Titel
Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons
verfasst von
Allison H. Maciver, MD, FRCSC
Eisar Al-Sukhni, MD, FRCSC
Jesus Esquivel, MD, FACS
Joseph J. Skitzki, MD, FACS
John M. Kane III, MD, FACS
Valerie A. Francescutti, MD, FRCSC, FACS
Publikationsdatum
29.11.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5692-3

Weitere Artikel der Ausgabe 4/2017

Annals of Surgical Oncology 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.